CTLA4 and neoplasm: ICIs, such as cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death 1 (PD-1) suppress T cell-mediated anti-tumor immune responses (Figure 6), leading to tumor progression [128].